HCM
HUTCHMED (China) LimitedHealthcare · $2.4B market cap
Verdict
Share price
$14.20
close of Oct 3, 2026
Fair value
$46.43
Sticker Price
Payback Price
$18.57
buy price
HCM is On Sale: at $14.20 it trades 24% below its buy price (Payback Price) of $18.57 and 69% below its fair value of $46.43. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
2 of 5 clear the 10% bar. What are the Big Five?
Follow HCM
Get notified when it reaches its buy price of $18.57. Free.
Create a free accountAbout HUTCHMED (China) Limited
HUTCHMED (China) Limited is a biopharmaceutical firm dedicated to the discovery, advancement, and marketing of innovative targeted and immune-based treatments for various cancers and immune-related disorders. Its operations are divided into two main areas: Oncology/Immunology and a segment encompassing Other Ventures. The company's reach extends from Hong Kong globally. Among its pipeline, HUTCHMED is developing…
Drug Manufacturers - Specialty & Generic
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works